Treatment or prophylaxis of retinal pathology and spinal...

Details Treatment or prophylaxis of retinal pathology and spinal... Treatment or prophylaxis of retinal pathology and spinal...

A - Human Necessities

01

N

A01N 37/12 (2006.01) A61K 38/05 (2006.01)

Patent

CA 2300135

Compositions containing 2-(phosphonomethyl)-pentanedioic acid (PMPA) and .alpha. and .beta. N-acetyl-aspartyl-glutamate (NAAG) are appropriate means for treatment of neuronal tissue injury that may result from such factors as injury, toxicity, hypoxia or ischemia (a frequent cause of hypoxia). Target tissues include the brain, spinal cord and retina.

Compositions contenant de l'acide 2-(phosphonométhyl)-pentanedioïque (PMPA) et .alpha. et .beta. N-acétyl-aspartyl-glutamate (NAAG) et constituant des moyens appropriés de traitement du traumatisme des tissus neuronaux pouvant être provoqué par des facteurs tels que le traumatisme, la toxicité, l'hypoxie ou l'ischémie (cause fréquente d'hypoxie). Les tissus ciblés comprennent le cerveau, la moelle épinière et la rétine.

Affiliated with

Also associated with

Rating

Treatment or prophylaxis of retinal pathology and spinal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment or prophylaxis of retinal pathology and spinal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment or prophylaxis of retinal pathology and spinal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1629269